头孢孟多
|
|
- CAS号:
- 34444-01-4
- 英文名:
- Cefamandole
- 英文别名:
- Florfenicol-d3 AMine;(r*)))-;cefadole;cephadole;cefamandol;CEFAMANDOLE;cephamandole;l-cefamandole;R hidalgoense;Compound-83405
- 中文名:
- 头孢孟多
- 中文别名:
- 头孢孟多;头孢孟多酯;原料头孢磺啶;S)-告依春;头孢孟多原料;原料头孢替考;莫沙必利杂质R;立他司特杂质R;阿普斯特R构型;1头孢替考原料
- CBNumber:
- CB2398185
- 分子式:
- C18H18N6O5S2
- 分子量:
- 462.5
- MOL File:
- 34444-01-4.mol
|
|
|
头孢孟多化学性质
-
熔点:
-
107-109oC
-
|
-
密度:
-
1.3806 (rough estimate)
-
|
-
折射率:
-
1.7000 (estimate)
-
|
-
储存条件:
-
Refrigerator
-
|
-
溶解度:
-
Chloroform (Sparingly), Methanol (Slightly)
-
|
-
酸度系数(pKa):
-
pKa 2.6–2.9 (Uncertain)
-
|
-
形态:
-
Oil
-
|
-
颜色:
-
Off-White
-
|
-
CAS 数据库:
-
34444-01-4(CAS DataBase Reference)
-
|
头孢孟多性质、用途与生产工艺
Cefamandole是第二代广谱头孢菌素类抗生素, 抗生素在体内分解, 释放游离NMTT, 可导致低凝血酶原血症。
用途
为抗生素类药
类别
有毒物质
可燃性危险特性
热分解排出有毒氮氧化物, 硫氧化物烟雾
储运特性
库房低温通风干燥
灭火剂
水,二氧化碳, 泡沫, 干粉
头孢孟多
上下游产品信息
上游原料
下游产品
头孢孟多
生产厂家
全球有 93家供应商
头孢孟多国内生产厂家
34444-01-4, 头孢孟多 相关搜索:
- Heterocycles
- Glucuronides
- Chiral Reagents
- 工业化
- 原料
- 对照品-杂质对照品
- 医药标准品
- C18H18N6O5S2
- 4444-01-4
- (6R,7R)-7-((R)-2-羟基-2-苯乙酰胺)-3-(((1-甲基-1H-四唑-5-基)硫代)甲基)-8-氧代-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 (头孢孟多酯钠杂质)
- 化合物TCN-201
- 头孢孟多酯钠EP杂质B
- 头孢替考1原料
- 1头孢替考原料
- 头孢孟多酯7位异构体对照品
- 头孢孟多酯△2异构体对照品
- 原料头孢替考
- 头孢孟多原料
- 原料头孢磺啶
- 头孢孟多酯杂质6
- S)-告依春
- 氢溴酸伏硫西汀杂质R
- 莫沙必利杂质R
- 立他司特杂质R
- 阿普斯特R构型
- 羟苄四唑头孢菌素
- 头孢孟多
- 7-[(2-羟基-2-苯基乙酰)氨基]-3-[(1-甲基四唑-5-基)硫甲基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-甲酸
- 头孢孟多酯
- 34444-01-4
- (6R,7R)-7-((R)-2-Hydroxy-2-phenylacetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (Cefmandole Sodium Impurity)
- Florfenicol-d3 AMine
- Cefamandole Nafate EP Impurity B
- Cefamandole USP/EP/BP
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7R)-
- R hidalgoense
- ApreMilast R isomers
- Lifitegrast impurity R
- Mosapride R isomer
- Vortioxetine Hydrobromide impurity R
- amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-,(6r-(6-alpha,7-beta
- 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid,7-((hydroxyphenylacetyl)
- (r*)))-
- CEFAMANDOLE
- l-cefamandole
- cephamandole
- cephadole
- cefamandol
- cefadole
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(hydroxyphenylacetyl)amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, [6R-[6α,7β(R*)]]-
- 3-(1-Methyltetrazol-5-ylthiomethyl)-7-D-mandelamido-3-cephem-4-carboxylic acid
- Compound-83405
- (6R,7R)-7α-[(R)-Hydroxy(phenyl)acetylamino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[(R)-Hydroxyphenylacetylamino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 7-[(2-Hydroxy-2-phenylacetyl)amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-hydroxyphenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7R)-
- N-[[(3R)-3,4-Dihydro-8-hydroxy-3-Methyl-1-oxo-1H-2-benzopyran-7-yl]carbonyl]-L-(phenyl-d5)alanine
- N-[(8-Hydroxy-3-Methyl-1-oxo-7-isochroManyl)carbonyl]-3-
(phenyl-d5)-L-alanine